Type B flu is one of the two main types of influenza virus that cause seasonal flu in humans each winter. It produces the same familiar symptoms as type A flu, including fever, body aches, cough, and fatigue, but it differs in important ways: it mutates more slowly, circulates only in humans, and tends to hit children and teenagers especially hard. Unlike type A, it cannot cause pandemics.
How Type B Differs From Type A
Influenza A and influenza B both drive seasonal flu epidemics, but they are fundamentally different viruses. Type A is divided into subtypes based on two surface proteins, with 18 and 11 known versions of each. That enormous genetic diversity is why type A is the only flu virus capable of sparking global pandemics. It also circulates in birds, pigs, and other animals, giving it opportunities to swap genetic material and create entirely new strains.
Type B, by contrast, has no subtypes at all. It circulates almost exclusively in humans, which limits its ability to undergo the dramatic shifts that create pandemic strains. It also mutates more slowly than type A, particularly compared to the A(H3N2) subtype that tends to cause the most severe seasonal outbreaks. This slower rate of change means your immune system retains some protection from past exposures for longer, though not indefinitely.
The Two B Lineages: Victoria and Yamagata
Instead of subtypes, type B flu is classified into two lineages: B/Victoria and B/Yamagata. These lineages diverged decades ago and have co-circulated ever since, sometimes in the same flu season. The distinction matters because infection with one lineage doesn’t reliably protect you against the other. For years, flu vaccines were formulated as quadrivalent shots that included strains from both B lineages alongside two type A strains. More recently, B/Yamagata has largely disappeared from global circulation, prompting vaccine manufacturers to shift back toward trivalent formulations that include only the B/Victoria lineage.
Symptoms and How Long They Last
Type B flu causes the same core symptoms as type A: sudden onset of fever, chills, muscle aches, sore throat, cough, headache, and fatigue. Some people also experience vomiting or diarrhea, particularly children. There is no reliable way to distinguish type A from type B based on symptoms alone. Both can range from mild to severe.
Symptoms typically appear about two days after exposure, though the incubation period can range from one to four days. You are most contagious during the first three days of illness, but the virus can be detected starting one day before symptoms appear and up to five to seven days after you get sick. Young children and people with weakened immune systems may remain contagious even longer. Most healthy adults recover within one to two weeks, though lingering fatigue and cough can persist.
Why Type B Hits Children Harder
Type B flu causes significant illness and death, particularly in children and adolescents. Adults have had more cumulative exposure to B strains over their lifetimes, which provides partial immunity. Children lack that built-up protection, making them more vulnerable to severe infection. Pediatric mortality data consistently show that type B accounts for a disproportionate share of flu-related deaths in children relative to how much it circulates overall. This is one reason public health officials emphasize that type B should not be dismissed as a “milder” form of flu.
Testing for Type B Flu
Rapid influenza diagnostic tests, the kind you can get at a doctor’s office or urgent care with results in about 15 minutes, can detect both type A and type B. However, they are slightly less sensitive for type B. The FDA requires these rapid tests to detect type B with at least 80% sensitivity compared to more advanced lab methods, meaning roughly 1 in 5 true type B infections could be missed. Specificity is high at 95%, so a positive result is reliable. If your rapid test is negative but your doctor suspects flu based on your symptoms and timing, a more accurate molecular test (RT-PCR) may be ordered.
Treatment Options
Antiviral medications work against both type A and type B flu, but the evidence suggests they are somewhat less effective against type B infections overall. The most commonly prescribed antiviral, oseltamivir (Tamiflu), reduces symptom duration for both types but appears to have a smaller benefit for type B.
A newer antiviral, baloxavir (Xofluza), may be a better option specifically for type B. In a randomized controlled trial, baloxavir reduced the time to symptom improvement by more than 24 hours compared to oseltamivir in adolescents and adults with type B infections. Baloxavir also has the advantage of being a single-dose treatment rather than a five-day course. Both medications work best when started within 48 hours of symptom onset.
Vaccination and Prevention
The annual flu vaccine remains the primary defense against type B flu. For years, quadrivalent vaccines included both B/Victoria and B/Yamagata lineage strains to cover whichever happened to dominate in a given season. With B/Yamagata fading from circulation, current vaccines are shifting to include only the B/Victoria component.
Vaccine effectiveness against type B varies from year to year depending on how well the vaccine strain matches what’s actually circulating. In general, flu vaccines provide moderate protection, reducing the risk of illness by roughly 40 to 60% in well-matched seasons. Even when the match isn’t perfect, vaccination tends to reduce the severity of illness if you do get infected. Beyond vaccination, the same measures that limit type A transmission apply: frequent handwashing, avoiding close contact with sick individuals, and staying home when you’re symptomatic, especially during those first three highly contagious days.